Ticker,Title,Link
VINC,Buy Rating Affirmed for Vincerx Pharma Amid Positive Clinical Progress and Stable Financial Outlook,8/13/2024 1:57:03 PM
VINC,VINC Stock Earnings: Vincerx Pharma Beats EPS for Q2 2024,8/9/2024 1:52:40 PM
VINC,Vincerx Pharma Reports Second Quarter 2024 Financial Results,8/8/2024 10:30:00 PM
VINC,"VINCI Secures Renewal Of Road Maintenance And Enhancement Contract In Milton Keynes, UK ",5/28/2024 4:50:51 AM
VINC,"Analysts Conflicted on These Healthcare Names: Cerevel Therapeutics Holdings (CERE), Cullinan Management (CGEM) and Vincerx Pharma Inc (VINC)",5/20/2024 6:30:56 AM
VINC,Vincerx Pharma GAAP EPS of -$0.58,5/15/2024 10:46:03 AM
VINC,Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update,5/14/2024 10:15:00 PM
VINC,"Vincerx Pharma dips 16%, prices $16M stock",4/26/2024 9:33:59 AM
VINC,Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants,4/25/2024 10:01:00 PM
VINC,Vincerx Pharma Inc (VINC) Gets a Buy from Leerink Partners,4/10/2024 6:21:17 AM
VINC,Crude Oil Down Over 1%; Cognyte Software Shares Plummet,4/9/2024 8:34:44 PM
VINC,Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 ,4/8/2024 10:30:00 PM
VINC,"Check-Cap, Outset Medical, Vincerx Pharma among healthcare movers",4/5/2024 2:01:19 PM
VINC,"Analysts Offer Insights on Healthcare Companies: Disc Medicine (IRON), Applied Therapeutics (APLT) and Vincerx Pharma Inc (VINC)",4/3/2024 6:01:04 AM
VINC,VINC Stock Earnings: Vincerx Pharma Beats EPS for Q4 2023,4/2/2024 11:53:14 AM
VINC,Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024,4/1/2024 2:00:00 PM
VINC,Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update,3/29/2024 8:20:52 PM
VINC,"OTRK, STRC and APM among mid-day movers",3/19/2024 4:48:26 PM
VINC,Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session,3/12/2024 7:07:32 PM
VINC,Buy Rating Affirmed for Vincerx Pharma Ahead of AACR Presentation: Promising Developments in Oncology Drug Pipeline,3/7/2024 4:18:35 AM
VINC,Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,3/6/2024 7:54:52 PM
VINC,Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024,3/5/2024 10:31:00 PM
VINC,"Catalyst Watch: Nvidia phenomenon, Amazon to the Dow and Anheuser-Busch drama",2/23/2024 8:00:00 PM
VINC,Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session,1/8/2024 7:36:31 PM
VINC,Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma,1/7/2024 9:00:00 PM
VINC,Leerink Partners Sticks to Its Buy Rating for Vincerx Pharma Inc (VINC),12/13/2023 6:22:33 AM
VINC,Vincerx Pharma Presents Preclinical VIP943 and VIP924 Posters at ASH 2023,12/10/2023 6:00:00 PM
VINC,"Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Vincerx Pharma Inc (VINC) and Pharvaris (PHVS)",11/16/2023 12:11:06 PM
VINC,Vincerx Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update,11/14/2023 1:00:00 PM
VINC,Vincerx Pharma To Present Three Posters at ASH 2023 in December,11/2/2023 2:10:00 PM
VINC,Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023,9/19/2023 1:00:00 PM
VINC,Vincerx Pharma Doses First Patient in the Phase 1 Clinical Trial Evaluating VIP943,9/14/2023 1:00:00 PM
VINC,Vincerx Pharma Announces FDA Clearance of IND for VIP943,8/22/2023 1:30:09 PM
VINC,Vincerx Pharma GAAP EPS of -$0.52,8/7/2023 2:55:18 PM
VINC,ARMP and VINC among mid-day movers,7/26/2023 4:59:58 PM
VINC,Vincerx Pharma Inc (VINC) Gets a Buy from SVB Securities,5/15/2023 10:06:04 AM
VINC,Vincerx Pharma GAAP EPS of -$0.68 misses by $0.03,5/12/2023 11:36:39 AM
VINC,"Scilex, Cytek top healthcare gainers; ZyVersa, Baudax among losers",4/26/2023 2:09:11 PM
VINC,Vincerx Pharma GAAP EPS of -$0.65 misses by $0.04,3/28/2023 9:10:38 PM
VINC,Why RAPT Therapeutics Shares Are Trading Lower By Over 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session,3/14/2023 6:07:10 PM
VINC,"YALA, ARDS and ORIC among mid-day movers",1/24/2023 5:58:27 PM
VINC,Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session,12/14/2022 8:12:59 PM
VINC,SVB Securities Sticks to Its Buy Rating for Vincerx Pharma Inc (VINC),11/14/2022 3:55:29 AM
VINC,Vincerx Pharma GAAP EPS of -$0.80 misses by $0.12,11/11/2022 5:01:59 AM
VINC,Vincerx Pharma Reports Third Quarter 2022 Financial Results and Provides a Corporate Update,11/10/2022 10:05:00 PM
VINC,SVB Securities Remains a Buy on Vincerx Pharma Inc (VINC),11/7/2022 3:35:48 AM
VINC,Vincerx Pharma Announces Upcoming Poster Presentations at the 64th American Society of Hematology (ASH) Annual Meeting 2022,11/3/2022 2:05:00 PM
VINC,Why F45 Training  Shares Climbed 41%; Here Are 84 Biggest Movers From Friday,10/3/2022 9:25:16 AM
VINC,"Spero, HeartBeam top healthcare gainers; MediWound, Vincerx lead losers' pack",9/22/2022 2:03:58 PM
VINC,5 Analysts Have This to Say About Vincerx Pharma,8/12/2022 8:20:26 PM
VINC,Vincerx Pharma Reports Second Quarter 2022 Financial Results and Provides a Corporate Update,8/11/2022 10:05:00 PM
VINC,Vincerx Pharma Presents Preclinical and Clinical Data on PTEFb/CDK9 Inhibitor VIP152 in Lymphoma at the European Hematology Association 2022 Congress,6/10/2022 2:00:00 PM
VINC,Vincerx Pharma discloses departure of medical chief,6/7/2022 8:47:15 PM
VINC,Vincerx Pharma Provides Key Strategic Update,6/6/2022 10:05:00 PM
VINC,Vincerx Pharma Reports First Quarter 2022 Financial Results and Provides a Corporate Update,5/12/2022 10:05:00 PM
VINC,Vincerx Pharma Presents Preclinical and Preliminary Clinical Data on PTEFb/CDK9 Inhibitor VIP152 in Gynecologic Malignancies at the American Association for Cancer Research (AACR) Annual Meeting 2022,4/8/2022 7:05:00 PM
VINC,Vincerx Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update,3/29/2022 2:00:00 PM
VINC,Vincerx Pharma Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2022,3/8/2022 10:35:00 PM
VINC,Vincerx Pharma to Participate in the SVB Leerink 11th Annual Global Healthcare Conference,2/9/2022 2:00:00 PM
VINC,Vincerx Pharma Publishes Preclinical Data Demonstrating Therapeutic Potential of Small Molecule-Drug Conjugate VIP236 in the Journal Cancers,2/3/2022 2:30:00 PM
VINC,"Benzinga's Top Ratings Upgrades, Downgrades For January 14, 2022",1/14/2022 4:03:39 PM
VINC,Vincerx Pharma climbs 4% on insider buying,12/27/2021 10:58:21 PM
VINC,Vincerx Pharma Announces First Patient Dosed in Phase 1 Dose-Escalation Study of VIP152 in Relapsed or Refractory Chronic Lymphocytic Leukemia or Richter Syndrome,12/17/2021 2:00:00 PM
VINC,Vincerx Pharma Presents Data on PTEFb/CDK9 Inhibitor VIP152 in DLBCL and CLL at the 63rd American Society of Hematology Annual Meeting,12/11/2021 9:30:00 PM
VINC,Vincerx Pharma Receives Orphan Drug Designation from European Commission for VIP152 for the Treatment of Diffuse Large B-Cell Lymphoma,12/7/2021 2:00:00 PM
VINC,Vincerx Pharma Hosting Key Opinion Leader Webinar on VIP152 Data Presented at the American Society of Hematology Annual Meeting,12/6/2021 2:00:00 PM
VINC,Vincerx Pharma Reports Third Quarter 2021 Financial Results and Provides a Corporate Update,11/12/2021 2:00:00 PM
VINC,Vincerx Pharma Announces Presentations at the American Society of Hematology Annual Meeting,11/4/2021 2:01:00 PM
VINC,"Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2021",11/1/2021 3:37:12 PM
VINC,Vincerx Pharma Announces $50 Million Private Placement,9/16/2021 1:30:00 PM
VINC,Vincerx Pharma to Participate in the 2021 Wells Fargo Virtual Healthcare Conference,9/7/2021 2:00:00 PM
VINC,"Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2021",8/25/2021 4:07:51 PM
VINC,60 Biggest Movers From Yesterday,8/24/2021 11:11:29 AM
VINC,Vincerx Pharma Reports Second Quarter 2021 Financial Results and Provides a Corporate Update,8/12/2021 10:05:00 PM
VINC,Vinci Partners Investments agrees to divest Domino’s Brasil to BK Brasil,7/12/2021 9:52:06 AM
VINC,58 Biggest Movers From Yesterday,7/2/2021 11:08:22 AM
VINC,Vincerx Pharma Announces Inclusion in Russell 3000® and Microcap® Indexes,6/28/2021 2:00:00 PM
VINC,"UPDATE -- Vincerx Pharma Presents Clinical Data on VIP152, its PTEFb/CDK9 Inhibitor, in Patients with Double-Hit Lymphoma at ASCO 2021",6/4/2021 6:40:09 PM
VINC,Vincerx Pharma Announces First Patient Dosed in Phase 1b Study of VIP152 in MYC-Driven Relapsed or Refractory Aggressive Lymphomas and Advanced Solid Tumors,6/3/2021 10:05:00 PM
VINC,"The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes",5/31/2021 5:06:35 PM
VINC,Vincerx Pharma to Participate in the Jefferies Virtual Healthcare Conference,5/26/2021 2:00:00 PM
VINC,Vincerx Pharma Reports First Quarter 2021 Financial Results and Provides a Corporate Update,5/17/2021 2:00:00 PM
VINC,Vincerx Pharma Announces Completion of Public Warrant Redemption,5/6/2021 2:00:00 PM
VINC,Vincerx Pharma Announces FDA Clearance of IND for Phase 1b Study of VIP152 in Chronic Lymphocytic Leukemia and Richter Syndrome,4/20/2021 2:00:00 PM
VINC,"Vincerx Pharma Presents Preclinical Data on VIP236, its Lead Small Molecule Drug Conjugate, at the American Association for Cancer Research Annual Meeting 2021",4/10/2021 2:31:00 PM
VINC,Vincerx Pharma To Host Key Opinion Leader Webinar on Bioconjugation and CDK9 Inhibitors for the Treatment of Hematologic and Solid Tumors,4/7/2021 2:00:00 PM
VINC,Vincerx Pharma Announces Redemption of Public Warrants,4/5/2021 2:00:00 PM
VINC,Vincerx Pharma Announces Formation of Scientific Advisory Board to Advance its Clinical Pipeline,4/1/2021 2:00:00 PM
VINC,Vincerx Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update,3/23/2021 1:00:00 PM
VINC,"The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs",3/19/2021 12:46:47 PM
VINC,"The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes",3/17/2021 12:43:08 PM
VINC,"The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study",3/16/2021 1:17:20 PM
VINC,Vincerx Pharma Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2021,3/10/2021 10:32:00 PM
VINC,Vincerx Pharma Strengthens Management Team with Three New Appointments,3/2/2021 2:00:00 PM
VINC,Seeking Alpha Catalyst Watch,2/26/2021 8:15:12 PM
VINC,Vincerx Pharma To Host Key Opinion Leader Webinar on VIP152 for the Treatment of Hematologic and Solid Tumors,2/24/2021 2:00:00 PM
VINC,Vincerx Pharma to Participate in the 10th Annual SVB Leerink Global Healthcare Conference,2/17/2021 2:00:00 PM
VINC,"The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision",2/3/2021 1:31:17 PM
VINC,"The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment",2/2/2021 2:05:48 PM
VINC,"The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO",1/29/2021 1:45:44 PM
VINC,"The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO",1/28/2021 2:03:49 PM
VINC,"The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs",1/8/2021 1:25:06 PM
VINC,Vincera Pharma Announces Name Change to Vincerx,1/7/2021 10:01:00 PM
VINC,"Benzinga's Top Upgrades, Downgrades For January 6, 2021",1/6/2021 4:14:45 PM
VINC,"The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data",1/5/2021 2:38:54 PM
VINC,Vincera Pharma Announces Completion of Business Combination and Listing on Nasdaq,12/23/2020 4:25:14 PM
